Sheng-nian, Z., Guo-yu, Z. & Li-qing, L. Therapeutic effects of Tongxinluo capsule on patients with acute small cerebral infarction and its influence on SPECT brain perfusion image., Chin. J. Integr. Med. 10, 107–111 (2004). https://doi.org/10.1007/BF02836378
Zhou Sheng-nian, Zhou Guo-yu, Liu Li-qing. Therapeutic effects of Tongxinluo capsule on patients with acute small cerebral infarction and its influence on SPECT brain perfusion image. [J]. Chinese Journal of Integrative Medicine 10(2):107-111(2004)
Sheng-nian, Z., Guo-yu, Z. & Li-qing, L. Therapeutic effects of Tongxinluo capsule on patients with acute small cerebral infarction and its influence on SPECT brain perfusion image., Chin. J. Integr. Med. 10, 107–111 (2004). https://doi.org/10.1007/BF02836378DOI:
Zhou Sheng-nian, Zhou Guo-yu, Liu Li-qing. Therapeutic effects of Tongxinluo capsule on patients with acute small cerebral infarction and its influence on SPECT brain perfusion image. [J]. Chinese Journal of Integrative Medicine 10(2):107-111(2004) DOI: 10.1007/BF02836378.
Therapeutic effects of Tongxinluo capsule on patients with acute small cerebral infarction and its influence on SPECT brain perfusion image
摘要
Objective: To investigate the influence of Tongxinluo capsule (TXL) on regional cerebral blood flow (rCBF) with 99mTc-ECD single photon emission computed tomography (SPECT) brain perfusion imaging
and to observe the therapeutic effects of TXL on acute small cerebral infarction (ASCI).Methods: Thirty-four patients with ASCI were enrolled and randomly divided into two groups: the control group (n = 17) was treated with the conventional treatment
i.e. 1. 0g of Citicoline added into 300 ml normal saline for intravenous dripping daily for 2 weeks and 0.8 g of Piracetam taken three times a day orally for 4 weeks
and the treatment group (n = 17) was treated additionally with 4 TXL capsules three times a day for 4 weeks besides the conventional treatment. The 99mTc-ECD SPECT brain perfusion imaging was performed before and after treatment to observe the change of rCBF
and the neurological deficit was evaluated by Edinburgh-Scandinavia stroke scale (SSS) scores and Barthel index (BI) at the same time.Results: After treatment
the rCBF in the treatment group was significantly improved (P<0.01)
while that in the control group remained unchanged
with the comparison of the rCBF in the two groups after treatment showing significant difference (P<0.01). In addition
the SSS score was significantly lower and Bl significantly higher in the treatment group than those in the control group respectively after treatment.Conclusion: TXL could effectively improve rCBF and lessen the neurological deficit symptoms in patients with ASCI.
Abstract
Objective: To investigate the influence of Tongxinluo capsule (TXL) on regional cerebral blood flow (rCBF) with 99mTc-ECD single photon emission computed tomography (SPECT) brain perfusion imaging
and to observe the therapeutic effects of TXL on acute small cerebral infarction (ASCI).Methods: Thirty-four patients with ASCI were enrolled and randomly divided into two groups: the control group (n = 17) was treated with the conventional treatment
i.e. 1. 0g of Citicoline added into 300 ml normal saline for intravenous dripping daily for 2 weeks and 0.8 g of Piracetam taken three times a day orally for 4 weeks
and the treatment group (n = 17) was treated additionally with 4 TXL capsules three times a day for 4 weeks besides the conventional treatment. The 99mTc-ECD SPECT brain perfusion imaging was performed before and after treatment to observe the change of rCBF
and the neurological deficit was evaluated by Edinburgh-Scandinavia stroke scale (SSS) scores and Barthel index (BI) at the same time.Results: After treatment
the rCBF in the treatment group was significantly improved (P<0.01)
while that in the control group remained unchanged
with the comparison of the rCBF in the two groups after treatment showing significant difference (P<0.01). In addition
the SSS score was significantly lower and Bl significantly higher in the treatment group than those in the control group respectively after treatment.Conclusion: TXL could effectively improve rCBF and lessen the neurological deficit symptoms in patients with ASCI.
Chinese Society of Neurology. Diagnostic outline of cerebral vascular diseases. Chin J Neurol 1996; 29(6): 379.
Multicenter trial of hemodilution in ischemic strokebackground and study protocol. Scandinavian Stroke Study Group. Stroke 1985; 16(5): 885–890.
Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. MdState Med J 1965; 14: 61–65.
Adams HPJr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24 (1): 35–41.
Bamford J, Sandercock P, Dennis M, et al. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991; 337 (8756): 1521–1526.
Huang RX. Treatment of ischemic cerebral vascular diseases based on different types and stages. Prev Treat Cardio Cereb Vasc Dis 2003; 3(1): 6–8.
Sun B, Wang ZC, Dai JP, et al. SPECT imaging of cerebral blood flow in diagnosis of intracranial disease. Chin J Neurosurg 1987; 3(4): 207–210.
Ueda T, Sakaki S, Yuh WT, et al. Outcome in acute stroke with successful intra-arterial thrombolysis and predictive value of initial single-photon emission-computed tomography. J Cereb Blood Flow Metab 1999; 19 (1): 99–108.
Andrei VA, Joseph CM, Michael DD, et al. Brain single-photon emission CT with HMPAO and safety of thrombolytic therapy in acute ischemic stroke: proceedings of the meeting of the SPECT safe thrombolysis study collaborators and the members of the brain imaging council of the society of nuclear medicine. Stroke 1997; 28: 1830–1834.
Butterworth RJ, Cluckie A, Jackson SH, et al. Pathophysiological assessment of nitric oxide (given as sodium nitroprusside) in acute ischemic stroke. Cerebrovasc Dis 1998; 8(3): 158–165.
Wang F, Jia SW. Effect of acupuncture on regional cerebral blood flow and cerebral functional activity evaluated with single-photon emission computed tomography. Chin J Integr Traditi West Med 1996; 16(6): 340–344.
Yao WX, Chang GJ, Xu ZQ, et al. Evaluation on the treatment of ischemie cerebral diseases with external counterpulsation by SPECT. Nuclear Techniques 1996; 19(11): 677–679.
Cao G, Jia XD, Wang XG, et al. Study on effect of Tongxinluo capsule on cerebral vessels in anaesthetized dog. Hebei J TCM 2000; 22(4): 315–317.
Wang XG, Li Q, Zhao SH, et al. Effect of Tongxinluo capsule on cerebral infarction caused impairment in experimental rats. Chin J Info TCM 2000; 7(6): 29.
Zhou HD, Deng J, Chen ME. Experimental study on protective effect of Tongxinluo capsule on rats undergoing cerebral ischemia/reperfusion. Chin J Crit Care Med 2001; 21(8): 435–437.
Luo AM, Li CL, Zhu XQ. Clinical observation of Tongxinluo capsule in treating cerebral infarction. Hebei Medicine 2002; 8(10): 871–873.